Whole exome sequencing identified a rare <i>WT1</i> loss-of-function variant in a non-syndromic POI patient

Yingchen Wang,Qing Chen,Feng Zhang,Xi Yang,Lingyue Shang,Shuting Ren,Yuncheng Pan,Zixue Zhou,Guoqing Li,Yunzheng Fang,Li Jin,Yanhua Wu,Xiaojin Zhang
DOI: https://doi.org/10.1002/mgg3.1820
2022-01-01
Molecular Genetics & Genomic Medicine
Abstract:Background: Premature ovarian insufficiency (POI) is a highly heterogeneous disease, and up to 25% of cases can be explained by genetic causes. The transcription factor WT1 has long been reported to play a crucial role in ovary function. Wt1-mutated female mice exhibited POI-like phenotypes. Methods and Results: In this study, whole exome sequencing (WES) was applied to find the cause of POI in Han Chinese women. A nonsense variant in the WT1 gene: NM_024426.6:c.1387C>T(p.R463*) was identified in a non-syndromic POI woman. The variant is a heterozygous de novo mutation that is very rare in the human population. The son of the patient inherited the mutation and developed Wilms' tumor and urethral malformation at the age of 7. According to the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG/AMP) guidelines, the novel variant is categorized as pathogenic. Western blot analysis further demonstrated that the WT1 variant could produce a truncated WT1 isoform in vitro. Conclusions: A rare heterozygous nonsense WT1 mutant is associated with non-syndromic POI and Wilms' tumor. Our finding characterized another pathogenic WT1 variant, providing insight into genetic counseling.
What problem does this paper attempt to address?